SMTL ID : 7wf5.2 (1 other biounit)

c-Src in complex with ponatinib

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x 0LI: 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzam ide(Non-covalent)

0LI.1: 25 residues within 4Å: Chain A: L.26, V.34, A.46, I.47, K.48, E.63, V.66, M.67, L.70, L.75, V.76, I.89, T.91, E.92, Y.93, M.94, G.97, V.136, H.137, R.138, L.146, V.155, A.156, D.157, F.158 18 PLIP interactions: 18 interactions with chain A Hydrophobic interactions: A:L.26, A:A.46, A:K.48, A:K.48, A:E.63, A:V.76, A:I.89, A:T.91, A:Y.93, A:L.146, A:D.157, A:F.158 Hydrogen bonds: A:E.63, A:M.94, A:D.157 Salt bridges: A:D.157 pi-Cation interactions: A:H.137 Halogen bonds: A:V.155

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Guo, M. et al., Structural study of ponatinib in inhibiting SRC kinase. Biochem.Biophys.Res.Commun. (2022)

Release Date

2022-03-02

Peptides

Proto-oncogene tyrosine-protein kinase Src: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Proto-oncogene tyrosine-protein kinase Src

Related Entries With Identical Sequence